Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox.
Cancer researchers have discovered that a notorious oncogene may occasionally wind up exposed on the outside of tumor cells, hinting at a surprising new immunotherapy target.
Meanwhile, Trump continues to win the messaging war on drug pricing, and biotech’s social circles get awkward again with an Epstein-linked investor’s return.
Continue to STAT+ to read the full story…
STAT Pharma: The science and business of new drug development
Leave a Reply